Shin Nippon Biomedical Laboratories, Ltd.

TSE:2395 Stok Raporu

Piyasa değeri: JP¥62.3b

Shin Nippon Biomedical Laboratories Yönetim

Yönetim kriter kontrolleri 2/4

Shin Nippon Biomedical Laboratories CEO'su Ryoichi Nagata, Jan1991 tarihinde atandı, in görev süresi 33.83 yıldır. şirketin hisselerinin 2.46% doğrudan sahiptir ve bu hisselerin değeri ¥ 1.53B dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.4 yıl ve 9.4 yıldır.

Anahtar bilgiler

Ryoichi Nagata

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi33.8yrs
CEO sahipliği2.5%
Yönetim ortalama görev süresi2.4yrs
Yönetim Kurulu ortalama görev süresi9.4yrs

Son yönetim güncellemeleri

Recent updates

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Sep 19
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts

Aug 09
Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts

Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding

Aug 06
Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 26
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 12
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 21
Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 10
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Mar 12
Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Feb 27
Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

CEO

Ryoichi Nagata (66 yo)

33.8yrs

Görev süresi

JP¥144,061,000

Tazminat

Dr. Ryoichi Nagata, M.D., Ph D., F.F.P.M., serves as President & Director of Satsuma Pharmaceuticals, Inc. since June 8, 2023 Also serves as it's Chief Executive Officer and Group Financial Officer since 2...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Ryoichi Nagata
President33.8yrsJP¥144.06m2.46%
¥ 1.5b
Fumihiko Makino
Senior Executive Officer2.8yrsVeri yokVeri yok
Toshiyuki Iwata
Managing Executive Officerno dataVeri yokVeri yok
Shinji Nitanda
Senior MD of Corporate Development & Corporate Tax Administration and Director2.4yrsVeri yokVeri yok
Kyomi Nagatoshi
Senior Managing Executive Officerno dataVeri yokVeri yok
Ken Takanashi
Executive VP of Group Corporate Management & Global Business & Director20.4yrsVeri yok0.090%
¥ 56.0m
Satoshi Matsumoto
Managing Executive Officer & GM of Fisheries Divisionless than a yearVeri yokVeri yok
Hideshi Tsusaki
Senior MD1.8yrsVeri yokVeri yok
Terumasa Hirai
Managing Executive Officer & President and Representative Director of SNBL Ina Research Centerno dataVeri yokVeri yok
Shu-Ichi Kanazashi
Managing Executive Officerless than a yearVeri yokVeri yok
Eishi Tsunozaki
Senior MD & Directorno dataVeri yok0.043%
¥ 27.1m
Ichiro Nagata
Executive VPno dataVeri yok40.32%
¥ 25.1b

2.4yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: 2395 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.4 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Ryoichi Nagata
President41.6yrsJP¥144.06m2.46%
¥ 1.5b
Shinji Nitanda
Senior MD of Corporate Development & Corporate Tax Administration and Director14.4yrsVeri yokVeri yok
Kyomi Nagatoshi
Senior Managing Executive Officerno dataVeri yokVeri yok
Ken Takanashi
Executive VP of Group Corporate Management & Global Business & Director21.9yrsVeri yok0.090%
¥ 56.0m
Hideshi Tsusaki
Senior MD10.4yrsVeri yokVeri yok
Eishi Tsunozaki
Senior MD & Director10.4yrsVeri yok0.043%
¥ 27.1m
Ichiro Nagata
Executive VP4.4yrsVeri yok40.32%
¥ 25.1b
Shinichi Fukumoto
Independent Outside Director9.4yrsVeri yok0.00096%
¥ 598.3k
Takashi Yamashita
Independent Outside Director9.4yrsVeri yok0.00096%
¥ 598.3k
Tsuyoshi Hanada
Independent Outside Director4.4yrsVeri yok0.0098%
¥ 6.1m
Keiko Totani
Independent Outside Director3.4yrsVeri yok0.0019%
¥ 1.2m
Chizuru Horishita
Independent Outside Directorless than a yearVeri yokVeri yok

9.4yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2395 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.4 yıldır).